Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Taylor

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|May 24, 2014
EVAPIL-R Scale: Continuous development and validation of a tool to assess patient-reported tolerability of different contraceptive methods in longitudinal studiesPierre Clerson, Olivier Graesslin, Adam Gater, et al.
AJR. American Journal of Roentgenology|September 22, 2012
MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experienceUday B Patel, Lennart K Blomqvist, Fiona Taylor, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Statins for the primary prevention of cardiovascular diseaseFiona Taylor, Kirsten Ward, Theresa Hm Moore, et al.
Annals of Surgical Oncology|May 19, 2011
MRI predictive factors for long-term outcomes of low rectal tumoursOliver C Shihab, Fiona Taylor, Gisella Salerno, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2017
Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer: Results from the CheckMate 017 StudyMartin Reck, Fiona Taylor, John R Penrod, et al.
BMJ Supportive & Palliative Care|January 14, 2025
Intersectionality factors and equitable end-of-life experiences: rapid reviewBriony F Hudson, Fiona Taylor, Rini Jones, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2021
FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrumentAlan L Shields, Roger E Lamoureux, Fiona Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2018
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057Martin Reck, Julie Brahmer, Bryan Bennett, et al.
The Cochrane Database of Systematic Reviews|February 27, 2013
Statins for the primary prevention of cardiovascular diseaseFiona Taylor, Mark D Huffman, Ana Filipa Macedo, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|May 24, 2014
EVAPIL-R Scale: Continuous development and validation of a tool to assess patient-reported tolerability of different contraceptive methods in longitudinal studiesPierre Clerson, Olivier Graesslin, Adam Gater, et al.
AJR. American Journal of Roentgenology|September 22, 2012
MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experienceUday B Patel, Lennart K Blomqvist, Fiona Taylor, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Statins for the primary prevention of cardiovascular diseaseFiona Taylor, Kirsten Ward, Theresa Hm Moore, et al.
Annals of Surgical Oncology|May 19, 2011
MRI predictive factors for long-term outcomes of low rectal tumoursOliver C Shihab, Fiona Taylor, Gisella Salerno, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2017
Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer: Results from the CheckMate 017 StudyMartin Reck, Fiona Taylor, John R Penrod, et al.
BMJ Supportive & Palliative Care|January 14, 2025
Intersectionality factors and equitable end-of-life experiences: rapid reviewBriony F Hudson, Fiona Taylor, Rini Jones, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 29, 2021
FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrumentAlan L Shields, Roger E Lamoureux, Fiona Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2018
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057Martin Reck, Julie Brahmer, Bryan Bennett, et al.
The Cochrane Database of Systematic Reviews|February 27, 2013
Statins for the primary prevention of cardiovascular diseaseFiona Taylor, Mark D Huffman, Ana Filipa Macedo, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
Pageof 9